Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil daily dosing versus intracavernosal alprostadil after nerve-sparing radical prostatectomy
ISRCTN32957197Phase 4Terminated
- Sponsor
- Johannes Gutenberg University Mainz
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sildenafil and Vasostenoon in erectile dysfunction (ED) (2 arms), sponsored by Johannes Gutenberg University Mainz. Primary endpoint: IIEF-EF domain score at week 42. Started Nov 2006; status: terminated.
02
Drugs
sildenafilVasostenoon
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on ISRCTN32957197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN32957197.